Aino Health AB AI Stock Analysis
Want to see SE:AINO full AI Analyst Report?
Aino Health AB (AINO) AI Stock Analysis
Aino Health AB
(Nasdaq OMX AB:AINO)
The overall score of 41 reflects a high-risk, distressed company. The most significant factors are the dire financial state, marked by insolvency, deep unprofitability, and severe cash burn. This is compounded by a bearish technical trend and a valuation that signals no fundamental support. The company's viability is a primary concern.
Aino Health AB (AINO) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 36.00M
- Dividend Yield
- ―
- Average Volume (3M)
- 85.10K
- Price to Earnings (P/E)
- -3.4
- Beta (1Y)
- 1.18
- Revenue Growth
- -10.72%
- EPS Growth
- -77.78%
- Country
- Sweden
- Employees
- 18
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Aino Health AB Business Overview & Revenue Model
Company Description
Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Softwa...
How the Company Makes Money
Aino Health AB primarily makes money by selling its digital health/absence-management solution and related services to business customers (employers/organizations). Revenue is generated through customer contracts for access to the company’s platform...
Aino Health AB Financial Statement Overview
Summary
Financial health is critically weak. The company is deeply unprofitable with a TTM net loss margin of -41.6%, is technically insolvent with negative equity of -11.3 million, and is burning cash with TTM operating cash flow of -6.0 million. The only positive is an improved gross margin, but it is overshadowed by severe operational and balance sheet distress.
Income Statement
8Very NegativeBalance Sheet
1Very NegativeCash Flow
10Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.50M | 26.11M | 23.94M | 23.92M | 19.91M | 23.04M |
| Gross Profit | 6.04M | -4.27M | 21.51M | 3.80M | 17.77M | 21.56M |
| EBITDA | -6.01M | -3.29M | -6.21M | -6.57M | -11.29M | -11.12M |
| Net Income | -9.79M | -6.11M | -9.91M | -10.66M | -14.96M | -15.22M |
Balance Sheet | ||||||
| Total Assets | 4.87M | 9.70M | 9.86M | 13.51M | 17.33M | 19.02M |
| Cash, Cash Equivalents and Short-Term Investments | 1.92M | 5.81M | 741.00K | 1.44M | 2.16M | 453.00K |
| Total Debt | 7.98M | 8.32M | 170.00K | 164.00K | 659.00K | 1.06M |
| Total Liabilities | 16.20M | 16.12M | 10.32M | 14.37M | 19.57M | 16.44M |
| Stockholders Equity | -11.33M | -6.42M | -458.00K | -851.00K | -2.23M | 2.58M |
Cash Flow | ||||||
| Free Cash Flow | -6.04M | -2.41M | -4.55M | -6.26M | -12.87M | -8.11M |
| Operating Cash Flow | -6.04M | -2.41M | -4.55M | -6.26M | -12.87M | -8.11M |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 1.32M | 0 |
| Financing Cash Flow | 7.21M | 7.62M | 3.82M | 5.57M | 13.19M | -450.00K |
Aino Health AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AINO, the sentiment is Negative. The current price of 0.18 is below the 20-day moving average (MA) of 0.19, below the 50-day MA of 0.19, and above the 200-day MA of 0.17, indicating a neutral trend. The MACD of -0.00 indicates Positive momentum. The RSI at 41.62 is Neutral, neither overbought nor oversold. The STOCH value of 32.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:AINO.
Aino Health AB Peers Comparison
Overall Rating
SE:SUS73Outperform
SE:PTRK59Neutral
SE:KONT47Neutral
SE:AINO41Neutral
SE:QLINEA41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | SEK 3.04B | 28.40 | ― | ― | 4.52% | 53.01% | |
| 59Neutral | SEK 171.55M | -1.95 | ― | ― | -10.30% | -11.59% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 47Neutral | SEK 45.12M | -42.41 | -1.94% | ― | 0.97% | 41.35% | |
| 41Neutral | SEK 36.00M | -3.44 | 105.04% | ― | -10.72% | -77.78% | |
| 41Neutral | SEK 215.07M | -1.31 | -48.10% | ― | 33.26% | 90.73% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:AINO | Aino Health AB | 0.18 | -0.03 | -15.38% | |
| SE:QLINEA | Q-linea AB | 11.15 | -13.80 | -55.31% | |
| SE:KONT | Kontigo Care AB | 1.19 | -0.86 | -42.20% | |
| SE:SUS | Surgical Science Sweden AB | 60.25 | -12.95 | -17.69% | |
| SE:PTRK | Physitrack Limited | 10.55 | -4.35 | -29.19% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
